Literature DB >> 25312821

miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC.

Huijie Gao1, Chao Liu2.   

Abstract

MicroRNAs are a class of endogenous non-coding RNAs that regulate gene expression at post-transcriptional level, thus participating in diverse biological pathways. Increasing miRNAs are found to dysregulate hepatocellular carcinoma (HCC) and are involved in liver tumorigenesis. In this study, miR-429 was found to obviously downregulate much more in hepatitis B virus (HBV)-related hepatocellular carcinoma. To evaluate the effects of miR-429, miR-429 was over-expressed in HepG2.2.15 cells. The results have proved that overexpression of miR-429 decreased cell proliferation and induced cell apoptosis. Further, overexpression of miR-429 can suppress the secretion of HBsAg and HBeAg. In concordance to this, the level of NOTCH1 expression was high in human HBV-related HCC tissues and HepG2.2.15 cells. MiR-429 directly targeted NOTCH1 and reduced both mRNA and protein levels of NOTCH1 which stimulated proliferation and suppressed apoptosis in HCC cells. Our results provide new insight into the function of miR-429 in HBV-related HCC. It is beneficial to insight into the mechanism of HBV infection and pathophysiology of HBV-related HCC.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hepatitis B virus (HBV); Hepatocellular carcinoma (HCC); MicroRNAs; NOTCH1; miR-429

Mesh:

Substances:

Year:  2014        PMID: 25312821     DOI: 10.1016/j.biopha.2014.09.005

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosis.

Authors:  Wen Hu; Jia Fu; Shi-Xun Lu; Li-Li Liu; Rong-Zhen Luo; Jing-Ping Yun; Chris Zhiyi Zhang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins.

Authors:  Wei Liu; Jie An; Kang Li; Huichi Hou
Journal:  Tumour Biol       Date:  2015-10-15

3.  Role of microRNAs in inflammation-associated liver cancer.

Authors:  Lin Huan; Lin-Hui Liang; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

4.  Several microRNAs could predict survival in patients with hepatitis B-related liver cancer.

Authors:  Ye Zhen; Zhao Xinghui; Wu Chao; Zhao Yi; Chen Jinwen; Gao Ruifang; Zhang Chao; Zhao Min; Guo Chunlei; Fang Yan; Du Lingfang; Shen Long; Shen Wenzhi; Luo Xiaohe; Xiang Rong
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

5.  miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.

Authors:  Chunmei Guo; Dongting Zhao; Qiuling Zhang; Shuqing Liu; Ming-Zhong Sun
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

6.  Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients.

Authors:  Xianliang Hou; Yan Liang; Jianing Chen; Yingfeng Wei; Ping Zeng; Lin Wang; Chong Lu; Hongyan Diao
Journal:  Biomed Res Int       Date:  2017-08-23       Impact factor: 3.411

7.  MicroRNA expression in bone marrow-derived human multipotent Stromal cells.

Authors:  Ian H Bellayr; Abhinav Kumar; Raj K Puri
Journal:  BMC Genomics       Date:  2017-08-11       Impact factor: 3.969

8.  miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.

Authors:  Min Zhang; Bing-Bin Dong; Min Lu; Mei-Juan Zheng; He Chen; Jing-Zhen Ding; A-Man Xu; Yuan-Hong Xu
Journal:  Onco Targets Ther       Date:  2016-03-03       Impact factor: 4.147

9.  miR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes.

Authors:  Ying Peng; Fen-Fen Chen; Jing Ge; Jia-Yu Zhu; Xin-E Shi; Xiao Li; Tai-Yong Yu; Gui-Yan Chu; Gong-She Yang
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

Review 10.  The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.

Authors:  Kurt Sartorius; Leo Swadling; Ping An; Julia Makarova; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.